Studies on combined adsorbed poliomyelitis-DTP vaccine. Poliomyelitis antibody responses of children to primary immunization.

Abstract

Acta PaediatricaVolume 51, Issue 4 p. 409-416 Studies on Combined Adsorbed Poliomyelitis-DTP Vaccine: Poliomyelitis Antibody Responses of Children to Primary Immunization P. HALONEN, Corresponding Author P. HALONEN State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumOrion Pharmaceutical Manufacturers Microbiological Laboratory Nilsiänkatu 10–14 Helsinki FinlandSearch for more papers by this authorJ. KAUHTIO, J. KAUHTIO State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorM. LAMY, M. LAMY State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorK. LAPINLEIMU, K. LAPINLEIMU State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorK. PENTTINEN, K. PENTTINEN State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorJ. PERHEENTUPA, J. PERHEENTUPA State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorR. TAMMILEHTO, R. TAMMILEHTO State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorN. TÖRNBLOM, N. TÖRNBLOM State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this author P. HALONEN, Corresponding Author P. HALONEN State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumOrion Pharmaceutical Manufacturers Microbiological Laboratory Nilsiänkatu 10–14 Helsinki FinlandSearch for more papers by this authorJ. KAUHTIO, J. KAUHTIO State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorM. LAMY, M. LAMY State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorK. LAPINLEIMU, K. LAPINLEIMU State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorK. PENTTINEN, K. PENTTINEN State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorJ. PERHEENTUPA, J. PERHEENTUPA State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorR. TAMMILEHTO, R. TAMMILEHTO State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this authorN. TÖRNBLOM, N. TÖRNBLOM State Serum Institute, Helsinki, Children's Castle, Helsinki, Microbiological Laboratory, Orion Pharmaceutical Manufacturers, Helsinki, Finland, and Vaccine Laboratory, R.I.T., Genval, BelgiumSearch for more papers by this author First published: July 1962 https://doi.org/10.1111/j.1651-2227.1962.tb06563.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume51, Issue4July 1962Pages 409-416 RelatedInformation